Results
1 -
10 of
49
(Click
here to explore results)
- Targeting a cell wall biosynthesis hot spot. Anna Müller, Anna Klöckner, Tanja Schneider
, Nat. Prod. Rep.
, 2017
, 34
, 909
- Inhibition of d-Ala incorporation into wall teichoic acid in Staphylococcus aureus by desleucyl-oritavancin. J. Chang, L. Coffman, S. J. Kim
, Chem. Commun.
, 2017
, 53
, 5649
- A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics. Paramita Sarkar, Venkateswarlu Yarlagadda, Chandradhish Ghosh, Jayanta Haldar
, Med. Chem. Commun.
, 2017
, 8
, 516
- Anti-cooperative ligand binding and dimerisation in the glycopeptide antibiotic dalbavancin. Mu Cheng, Zyta M. Ziora, Karl A. Hansford, Mark A. Blaskovich, Mark S. Butler, Matthew A. Cooper
, Org. Biomol. Chem.
, 2014
, 12
, 2568
- Cyclic peptide drugs approved in the last two decades (2001–2021). Huiya Zhang, Shiyu Chen
, RSC Chem. Biol.
, 2022
, 3
, 18
- Application of REDOR
NMR in natural product chemistry. Shigeru Matsuoka, Masayuki Inoue
, Chem. Commun.
, 2009
, 5664
- Bacterial lipid membranes as promising targets to fight antimicrobial resistance, molecular foundations and illustration through the renewal of aminoglycoside antibiotics and emergence of amphiphilic aminoglycosides. Marie-Paule Mingeot-Leclercq, Jean-Luc Décout
, Med. Chem. Commun.
, 2016
, 7
, 586
- Structural diversity, biosynthesis, and biological functions of lipopeptides from Streptomyces. Songya Zhang, Yunliang Chen, Jing Zhu, Qiujie Lu, Max J. Cryle, Youming Zhang, Fu Yan
, Nat. Prod. Rep.
, 2023
, 40
, 557
- Recent advances in the synthesis of new glycopeptide antibiotics. Polly-Anna Ashford, Sean P. Bew
, Chem. Soc. Rev.
, 2012
, 41
, 957
- Natural products to drugs: natural product derived compounds in clinical trials. Mark S. Butler
, Nat. Prod. Rep.
, 2005
, 22
, 162